← Browse by Condition
Medical Condition
covid 19 recurrent
Total Trials
1
Recruiting Now
1
Trial Phases
Various
COVID-19 trials proliferated rapidly during the pandemic and now encompass antiviral treatments, long COVID management, and ongoing vaccine refinements for new variants. The platform trial model — where multiple interventions share a single control arm — was pioneered at scale for COVID-19 (RECOVERY, ACTIV-3, SOLIDARITY) and has since been adopted across other disease areas.
Active trials address long COVID (fatigue, cognitive impairment, autonomic dysfunction), antiviral combinations for high-risk outpatients, mucosal vaccines for variant-resistant immunity, and mechanistic studies into post-COVID organ damage. Paxlovid rebound, nirmatrelvir resistance, and immunocompromised host management are current investigation areas.
Top Sponsors
1 trial
Recruiting Clinical Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology